Overview

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine
Tolterodine Tartrate